Stocks and Investing Stocks and Investing
Tue, May 24, 2022

Madhu Kumar Maintained (APLS) at Strong Buy with Decreased Target to $84 on, May 24th, 2022


Published on 2024-10-27 21:15:43 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Goldman Sachs, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $94 to $84 on, May 24th, 2022.

Madhu has made no other calls on APLS in the last 4 months.



There are 5 other peers that have a rating on APLS. Out of the 5 peers that are also analyzing APLS, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $44 on, Thursday, May 5th, 2022


These are the ratings of the 4 analyists that currently disagree with Madhu


  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $102 on, Thursday, May 5th, 2022
  • Elemer Piros of "Roth Capital" Downgraded from Hold to Strong Sell and Held Target at $40 on, Thursday, April 14th, 2022
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022
  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
Contributing Sources